US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

304.16

-13.0400-4.11%

Volume:243.62K

Turnover:73.28M

Market Cap:646.18M

PE:- -

High:312.79

Open:312.10

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:1.58

T/O Rate:11.47%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)

Ultragenyx Pharmaceutical (RARE) Stock Jumps 9% on Accelerated FDA Approval

Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Viridian Therapeutics (VRDN)

Rhelion’s Filament Health to Harness FDA-Authorized AI Imaging in Psilocybin Alzheimer’s Trial Design

Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate

Simply Wall St.

Regeneron’s Pasatru granted FDA approval for FOP

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)

Protagenic receives FDA pre-IND feedback supporting IND for PT00114

EXL earns dual Leader recognition in ISG’s 2026 Healthcare AI Report, cited for moving AI from pilots to enterprise scale

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Genscript Biotech (OtherGNNSF) and Cochlear (OtherCHEOF)

Hyperfine announces FDA clearance of Optive AI software update

Analysts Offer Insights on Real Estate Companies: Equinix (EQIX), National Healthcare Properties (NHP) and Vicinity Centres (OtherCNRAF)

TempraMed Wins Maccabi Contract Extension as Board Member Steps Down

OrthoPediatrics (KIDS) Receives a Buy from BTIG

Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN) and Olema Pharmaceuticals (OLMA)

Health Care Roundup: Market Talk

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Iridex (IRIX) and Aurora Cannabis (ACB)

Ascelia Pharma Tightens Costs After FDA Setback on Orviglance

The 60/40 Portfolio is 'Broken.' Here's How to Fix It.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":304.16,"timestamp":1787585310189,"preClose":317.2,"halted":0,"volume":243623,"delay":0,"changeRate":-0.04110970996216887,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Trading","change":-13.04,"latestTime":"08-24 11:28:39 EDT","open":312.1,"high":312.79,"low":293,"amount":73283905.73895,"amplitude":0.06239,"askPrice":305.18,"askSize":330,"bidPrice":303.63,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003337,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":1.576898,"impliedVol":0.9645,"impliedVolPercentile":0.741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.576898,"shares":2124486,"dividePrice":1.015,"high":312.79,"amplitude":0.06239,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":304.16,"committee":-0.833333,"eps":0,"divideRate":0.003337,"volume":243623,"delay":0,"ttmEps":0,"open":312.1,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660801452","title":"Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660801452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660801452?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:50","pubTimestamp":1787233811,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH). ID...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ideaya-biosciences-idya-and-definitive-healthcare-corp-dh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ideaya-biosciences-idya-and-definitive-healthcare-corp-dh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DH","BK4581","LABU","BK4139","BK4588","XLV","XBI","BK4585","IDYA","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660280813","title":"Ultragenyx Pharmaceutical (RARE) Stock Jumps 9% on Accelerated FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2660280813","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660280813?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:43","pubTimestamp":1787233424,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical stock rallied 8.99% on Thursday after the FDA granted Ultragenyx Pharmaceutical’s GENGLYCOS accelerated approval.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ultragenyx-pharmaceutical-rare-stock-jumps-9-on-accelerated-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ultragenyx-pharmaceutical-rare-stock-jumps-9-on-accelerated-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE","LABU","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287027","title":"Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287027?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233213,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Health Catalyst (HCAT) and Viridian Therapeutics (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-health-catalyst-hcat-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-health-catalyst-hcat-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","HCSG","HCAT","VRDN","XLV","BK4588","BK4581","XBI","BK4139","LABU","BK4585","LU0029874061.USD","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428705","title":"Rhelion’s Filament Health to Harness FDA-Authorized AI Imaging in Psilocybin Alzheimer’s Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428705?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:38","pubTimestamp":1787233139,"startTime":"0","endTime":"0","summary":"Red Light Holland ( ($TSE:RHEL) ) has issued an update. Rhelion Life Sciences’ subsidiary Filament Health has signed a non-binding letter of intent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rhelions-filament-health-to-harness-fda-authorized-ai-imaging-in-psilocybin-alzheimers-trial-design?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rhelions-filament-health-to-harness-fda-authorized-ai-imaging-in-psilocybin-alzheimers-trial-design?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","ARTY","QTOC","AGIX","AIPO","VTHR","CHAT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660633238","title":"Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660633238","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660633238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:30","pubTimestamp":1787232636,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) announced that the U.S. FDA has accepted its New Drug Application for ecopipam for pediatric Tourette syndrome with Priority Review status.\nEcopipam is described by Teva as a first in class therapy candidate targeting children and adolescents with Tourette syndrome, an area where no new treatments have been approved in over a decade.\nThe filing is backed by positive late stage clinical trial data and adds another potential branded medicine to Teva's...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/teva-teva-wins-fda-priority-review-for-pediatric-tourette-dr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/teva-teva-wins-fda-priority-review-for-pediatric-tourette-dr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","TEVA","BK4585","LU2324357040.USD","BK4566","LU1983299246.USD","BK4584","BK4596","BK4559","BK4588","BK4557","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","GNMX","TBXU","IEIH","IBB","MRNY","NVIB","XLVX","BK4588","LABU","GDOC","MEDI","LFSC","FRTY","IYH","RSPH","BK4585","TECB","MRNX","BBP","SYNB","IDNA","PINK","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282499","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282499","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282499?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:01","pubTimestamp":1787230902,"startTime":"0","endTime":"0","summary":"Healthcare stocks were leaning lower pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  down 0.5% and the iShares Biotechnology ETF  declining by 1%.Ultragenyx Pharmaceutical  has received accelerated approval from the US Food and Drug Administration for Genglycos to treat glycogen storage disease type Ia, a rare genetic metabolic disorder due to an enzyme deficiency, the drugmaker said. Ultragenyx Pharmaceutical shares were up more than 6% premarket.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","BK4581","BK4585","BK4137","LU0128526141.USD","LU0029874061.USD","XLV","BK4139","IBB","XBI","BK4588","RARE","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282761","title":"Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282761?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:00","pubTimestamp":1787230821,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-ultragenyx-pharmaceutical-rare-and-cytokinetics-cytk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-ultragenyx-pharmaceutical-rare-and-cytokinetics-cytk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0211326755.USD","LU1989764664.SGD","LU0432979614.USD","IE00BGHQF631.EUR","IE00B3T34201.USD","BK4139","LU0976567544.SGD","LU0320765489.SGD","LU2089284900.SGD","BK4082","BK4505","IE00B42XCP33.USD","MDT","BK4566","LU0314106906.USD","LU0106261372.USD","LABU","LU0029874061.USD","LU1116320901.HKD","LU2112291526.USD","LU1989771016.USD","LU0211331839.USD","LU0265550946.USD","IE00BQXX3F31.USD","LU1244550577.SGD","IE00BQXX3D17.EUR","LU0006306889.USD","LU2023251221.USD","LU1571399168.USD","BK4581","CYTK","XBI","LU0158827948.USD","LU2468319806.SGD","IE00BDGV0183.EUR","IE00BVYPNW00.USD","IE00BFXG1179.USD","LU1023059063.AUD","LU1506573853.SGD","LU2271345857.HKD","LU0496365809.HKD","LU1983299246.USD","RARE","BK4588","XLV","HCSG","BK4533","LU2089283258.USD","LU0211326839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660735282","title":"Protagenic receives FDA pre-IND feedback supporting IND for PT00114","url":"https://stock-news.laohu8.com/highlight/detail?id=2660735282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660735282?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:50","pubTimestamp":1787230244,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics (PTIX) announced that it has received written responses from the U.S. Food and Drug Administration, FDA, to its Type B pre-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagenic-receives-fda-pre-ind-feedback-supporting-ind-for-pt00114-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagenic-receives-fda-pre-ind-feedback-supporting-ind-for-pt00114-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4588","BK4585","PTIX","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282862","title":"EXL earns dual Leader recognition in ISG’s 2026 Healthcare AI Report, cited for moving AI from pilots to enterprise scale","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282862","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282862?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:32","pubTimestamp":1787229120,"startTime":"0","endTime":"0","summary":"NEW YORK, Aug.  20, 2026 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, announced it has been recognized as a Leader in both the Healthcare AI Strategy and Advisory Services and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348365/9060/en/exl-earns-dual-leader-recognition-in-isg-s-2026-healthcare-ai-report-cited-for-moving-ai-from-pilots-to-enterprise-scale.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOBL","BK4106","BK4581","LABU","EXLS","BK4550","IXJ","XLV","LU0054578231.USD","BK4588","HAIAU","TCAF","ARTY","AIPO","AGIX","VTHR","VHT","CHAT","BK4585","LU0053671581.USD","QTOC","CGCV","XBI","BK4226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660628463","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Genscript Biotech (OtherGNNSF) and Cochlear (OtherCHEOF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660628463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660628463?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:20","pubTimestamp":1787228439,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genscript Biotech (GNNSF) and Cochlear (CHEOF). Genscript Biotech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-genscript-biotech-othergnnsf-and-cochlear-othercheof-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-genscript-biotech-othergnnsf-and-cochlear-othercheof-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GNNSF","LU0128526141.USD","HCSG","BK4121","BK4082","CHEOF","XBI","BK4137","BK4581","LABU","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660594284","title":"Hyperfine announces FDA clearance of Optive AI software update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660594284","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660594284?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:20","pubTimestamp":1787228435,"startTime":"0","endTime":"0","summary":"Hyperfine (HYPR) announced that it has received FDA clearance for its latest Optive AI software update. This advancement is Hyperfine’s second FDA-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hyperfine-announces-fda-clearance-of-optive-ai-software-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hyperfine-announces-fda-clearance-of-optive-ai-software-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","VTHR","BK4082","EPAI","QTOC","HYPR","AIQU","CHAT","IGM","WDAI","AGIX","AIHY","AIPO","BK4585","LABU","QQH","BK4588","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660628455","title":"Analysts Offer Insights on Real Estate Companies: Equinix (EQIX), National Healthcare Properties (NHP) and Vicinity Centres (OtherCNRAF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660628455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660628455?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:20","pubTimestamp":1787228428,"startTime":"0","endTime":"0","summary":"Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Equinix (EQIX), National Healthcare Properties (N...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-equinix-eqix-national-healthcare-properties-nhp-and-vicinity-centres-othercnraf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-equinix-eqix-national-healthcare-properties-nhp-and-vicinity-centres-othercnraf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRT","RWR","JRE","RNTY","ERET","BBRE","URE","BK4588","WTRE","XLRE","BK4222","DFGR","XLV","EQIX","CRED","IQRA","PPTY","FRI","DTCR","IVEP","VGSR","FREL","DPRE","BK4529","ICF","JPRE","DFAR","RWO","BK4084","GQRE","IYRI","SCHH","TRUR","BYRE","BK4566","PSR","REET","XBI","BK4567","REIT","IYR","IDGT","AVRE","LABU","NHP","DTRE","SPRE","SRVR","VNQ","REAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660289753","title":"TempraMed Wins Maccabi Contract Extension as Board Member Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2660289753","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660289753?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:39","pubTimestamp":1787225990,"startTime":"0","endTime":"0","summary":"TempraMed Technologies Ltd. ( ($TSE:VIVI) ) just unveiled an update. TempraMed Technologies Ltd. reported that Maccabi Healthcare Services, Israel’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tempramed-wins-maccabi-contract-extension-as-board-member-steps-down?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tempramed-wins-maccabi-contract-extension-as-board-member-steps-down?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660289785","title":"OrthoPediatrics (KIDS) Receives a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2660289785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660289785?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:35","pubTimestamp":1787225736,"startTime":"0","endTime":"0","summary":"BTIG analyst Ryan Zimmerman assigned a Buy rating to OrthoPediatrics today and set a price target of $29.00. Zimmerman covers the Healthcare sector...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/orthopediatrics-kids-receives-a-buy-from-btig-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/orthopediatrics-kids-receives-a-buy-from-btig-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4585","BK4588","BK4581","XLV","XBI","LABU","KIDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660531289","title":"Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN) and Olema Pharmaceuticals (OLMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660531289","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660531289?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:20","pubTimestamp":1787224831,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Smith & Nephew Snats (SNN) and Olema Pharmaceuticals (OLMA). Smit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-smith-nephew-snats-snn-and-olema-pharmaceuticals-olma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-smith-nephew-snats-snn-and-olema-pharmaceuticals-olma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4139","SNN","BK4137","BK4082","HCSG","BK4585","BK4588","LU0128526141.USD","OLMA","LU0029874061.USD","LABU","XLV","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404048","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404048","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404048?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:20","pubTimestamp":1787214000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0501 GMT - Summerset's balance sheet is once again likely to dom","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015358.SGD","LABU","JDOC","RXL","XLV","LU1066051498.USD","LU1989772923.USD","FTXH","LU2324357040.USD","LU0320765646.SGD","LU0965509010.AUD","SG9999014559.SGD","SG9999014542.SGD","LU0006306889.USD","LU2361045086.USD","IHE","VHT","LU2361044949.HKD","XBI","LU0859254822.USD","LU1037948541.HKD","FHLC","LU1037948897.HKD","LU0823416689.USD","LU0965509101.SGD","BMED","GDOC","LU1941712348.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","TRUH","LU1069347547.HKD","HRTS","LU1934455277.USD","LU2491050154.USD","LU2125154935.USD","LU1066051811.HKD","LU0208291251.USD","LU0238689110.USD","IXJ","IYH","IE00BN8TJ469.HKD","LU0265550359.USD","LU0289739699.SGD","LU2361044865.SGD","MRK","PPH","LU1699723380.USD","SG9999015341.SGD","PAWZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660401811","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Iridex (IRIX) and Aurora Cannabis (ACB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660401811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660401811?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:20","pubTimestamp":1787210412,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Iridex (IRIX) and Aurora Cannabis (ACB). Iridex (IRIX) Alliance G...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-iridex-irix-and-aurora-cannabis-acb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-iridex-irix-and-aurora-cannabis-acb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","CNBS","LU0029874061.USD","ACB","BK4585","MJ","BK4557","XBI","YOLO","BK4581","BK4007","BK4588","MSOS","LABU","BK4137","TOKE","HCSG","WEED","MSOX","IRIX","BK4082","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660056405","title":"Ascelia Pharma Tightens Costs After FDA Setback on Orviglance","url":"https://stock-news.laohu8.com/highlight/detail?id=2660056405","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660056405?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:03","pubTimestamp":1787205799,"startTime":"0","endTime":"0","summary":"An announcement from Ascelia Pharma AB ( ($SE:ACE) ) is now available. Ascelia Pharma reported that its primary focus in the first half of 2026 has...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ascelia-pharma-tightens-costs-after-fda-setback-on-orviglance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ascelia-pharma-tightens-costs-after-fda-setback-on-orviglance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4554","LU2045819591.USD","LABU","SG9999002679.SGD","SG9999013460.SGD","LU2177674079.SGD","FDNI","LU0737861269.HKD","BK4503","BK4581","LU0345776255.USD","LU0572940350.SGD","LU1048588211.SGD","SG9999002406.SGD","SG9999013486.USD","BK4535","IE0001KFT4U8.USD","LU0823038988.USD","LU0532188223.SGD","BK4551","BK4585","LU0345775950.USD","LU0823039010.USD","LU1861220207.SGD","LU0264606111.USD","LU2008162690.USD","LU0072462343.USD","IE00BD6J9T35.USD","BK4085","LU2543165471.USD","BK4548","SE","LU0261945553.USD","LU0516422440.USD","LU0979878070.USD","SG9999013478.USD","SG9999002604.SGD","SG9999002620.SGD","IE0031814969.USD","SG9999005177.SGD","BK4566","LU0589944569.HKD","LU0499858602.USD","IE0034224299.USD","LU0516422366.SGD","LU2238330802.EUR","LU1770036033.HKD","LU0572939691.SGD","LU2152927971.USD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660405176","title":"The 60/40 Portfolio is 'Broken.' Here's How to Fix It.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660405176","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660405176?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:00","pubTimestamp":1787205600,"startTime":"0","endTime":"0","summary":"With bond markets selling off, 60/40 investors are once again in a tight spot.While there is no cure-all for treacherous market conditions, there are some tweaks you can make to smooth returns, such a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689605.HKD","XBI","FDFF","ARTY","PRTO","BAC","LU0787776722.HKD","AGIX","BK4207","LU1481011911.USD","BK4135","IE0001KFT4U8.USD","IE00B64PRP62.GBP","LU2592432038.USD","IYG","VFH","BNDW","LABU","BK4535","IE0002270589.USD","IE00B1BXHZ80.USD","LU0306806265.USD","LU1670627923.USD","KBWB","LU0868494617.USD","XLF","AIPO","LU2133065610.SGD","LU0203347892.USD","QTOC","FNCL","BLK","XLV","IYF","LU2129689514.USD","LU2265009873.SGD","FTXO","LU1988902786.USD","LU1064131342.USD","LU0971096721.USD","LU1894683264.USD","TFNS","UYG","BK4559","LU0310800965.SGD","CHAT","IE00B3PB1722.GBP","IE00B19Z3B42.SGD","IE00BGHQF748.EUR","VTHR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":403,"code":"91000000","status":"200"}]}}